Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matveev

Showing results (941-950 of 1,381) with videos related to

Pageof 139
Sort By:
The Lancet. Oncology|June 8, 2013
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trialIan F Tannock, Karim Fizazi, Sergey Ivanov, et al.
International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.
Acta Naturae|June 1, 2012
Combining two technologies for full genome sequencing of humanK G Skryabin, E B Prokhortchouk, A M Mazur, et al.
Scientific Reports|February 3, 2017
Photodynamic therapy monitoring with optical coherence angiographyM A Sirotkina, L A Matveev, M V Shirmanova, et al.
Scientific Reports|September 27, 2024
The impact of the tumor microenvironment on the survival of penile cancer patientsStefan Lohse, Jan Niklas Mink, Lea Eckhart, et al.
Molecules (Basel, Switzerland)|May 28, 2022
First Trifluoromethylated Phenanthrolinediamides: Synthesis, Structure, Stereodynamics and Complexation with Ln(III)Yuri A Ustynyuk, Pavel S Lemport, Vitaly A Roznyatovsky, et al.
RSC Advances|May 6, 2022
The impact of alicyclic substituents on the extraction ability of new family of 1,10-phenanthroline-2,9-diamidesPavel S Lemport, Petr I Matveev, Alexander V Yatsenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell CarcinomaDavid F McDermott, Jae-Lyun Lee, Marek Ziobro, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 2, 2023
Evaluation of Optic Disc Edema in Long-Duration Spaceflight Crewmembers Using Retinal PhotographyWilliam E Valencia, Sara S Mason, Tyson J Brunstetter, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|October 6, 2009
[Composite phytoadaptogens in oncology and gerontology]O A Bocharova, M I Davydov, A Iu Baryshnikov, et al.
Pageof 139

Showing results (941-950 of 1,381) with videos related to

Sort By:
Pageof 139
The Lancet. Oncology|June 8, 2013
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trialIan F Tannock, Karim Fizazi, Sergey Ivanov, et al.
International Journal of Cancer|June 9, 2023
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trialSun Young Rha, Toni K Choueiri, Vsevolod B Matveev, et al.
Acta Naturae|June 1, 2012
Combining two technologies for full genome sequencing of humanK G Skryabin, E B Prokhortchouk, A M Mazur, et al.
Scientific Reports|February 3, 2017
Photodynamic therapy monitoring with optical coherence angiographyM A Sirotkina, L A Matveev, M V Shirmanova, et al.
Scientific Reports|September 27, 2024
The impact of the tumor microenvironment on the survival of penile cancer patientsStefan Lohse, Jan Niklas Mink, Lea Eckhart, et al.
Molecules (Basel, Switzerland)|May 28, 2022
First Trifluoromethylated Phenanthrolinediamides: Synthesis, Structure, Stereodynamics and Complexation with Ln(III)Yuri A Ustynyuk, Pavel S Lemport, Vitaly A Roznyatovsky, et al.
RSC Advances|May 6, 2022
The impact of alicyclic substituents on the extraction ability of new family of 1,10-phenanthroline-2,9-diamidesPavel S Lemport, Petr I Matveev, Alexander V Yatsenko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2021
Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell CarcinomaDavid F McDermott, Jae-Lyun Lee, Marek Ziobro, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 2, 2023
Evaluation of Optic Disc Edema in Long-Duration Spaceflight Crewmembers Using Retinal PhotographyWilliam E Valencia, Sara S Mason, Tyson J Brunstetter, et al.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|October 6, 2009
[Composite phytoadaptogens in oncology and gerontology]O A Bocharova, M I Davydov, A Iu Baryshnikov, et al.
Pageof 139